Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 PS Ratio is 17.46 as of Jul. 18, 2026, which is 35% above its 10-year median of 12.98. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 661 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks worse than 94.4% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Gaudium IVF And Women Health's share price is ₹143.78.
Gaudium IVF And Women Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.23. Hence, Gaudium IVF And Women Health's PS Ratio for today is 17.46.
Good Sign:
Gaudium IVF And Women Health Ltd stock PS Ratio (=7.44) is close to 1-year low of 7.44.
The historical rank and industry rank for Gaudium IVF And Women Health's PS Ratio or its related term are showing as below:
NSE:GAUDIUMIVF'
s PS Ratio Range Over the Past 10 Years
Min: 9.29 Med: 12.98 Max: 17.46
Current: 17.46
During the past 5 years, Gaudium IVF And Women Health's highest PS Ratio was 17.46. The lowest was 9.29. And the median was 12.98.
NSE:GAUDIUMIVF's PS Ratio is ranked worse than 94.4% of 661
companies
in the Healthcare Providers & Services industry
Industry Median: 1.52
vs NSE:GAUDIUMIVF: 17.46
During the past 5 years, Gaudium IVF And Women Health's highest 3-Year average Revenue per Share Growth Rate was 40.10% per year. The lowest was 24.60% per year. And the median was 32.35% per year.
Back to Basics: PS Ratio
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Gaudium IVF And Women Health PS Ratio Related Terms
Gaudium IVF And Women Health PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:GAUDIUMIVF vs HCA, THC, DVA: PS Ratio Comparison
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's PS Ratio distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Gaudium IVF And Women Health's Share Price of today is ₹143.78. Gaudium IVF And Women Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a PS Ratio of 17.46 as of Jul. 18, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gaudium IVF And Women Health and its competitors. This is 35% above median its historical median of 12.98. Over the past decade, Gaudium IVF And Women Health's PS Ratio has ranged from 9.29 to 17.46. According to the industry distribution chart, Gaudium IVF And Women Health ranks #624 out of 661 companies in the Healthcare Providers & Services industry, placing it in the top 94.4%.
Is Gaudium IVF And Women Health's PS Ratio too high?
Gaudium IVF And Women Health's current PS Ratio of 17.46 is 35% above median its 10-year median of 12.98. Over the past 10 years, this metric has ranged from a low of 9.29 to a high of 17.46. The Healthcare Providers & Services industry median PS Ratio is 1.52. Gaudium IVF And Women Health's value of 17.46 is 1048.7% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #624 out of 661 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #624 out of 661 companies for PS Ratio. This places Gaudium IVF And Women Health in the lower half of its industry. The industry median PS Ratio is 1.52. Gaudium IVF And Women Health's value of 17.46 is 1048.7% above this benchmark. Historically, Gaudium IVF And Women Health's own PS Ratio has ranged from 9.29 to 17.46 over the past decade. While the company's 10-year median is 12.98 vs. the industry median of 1.52, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.52, based on 661 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current PS Ratio of 17.46 is 1048.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current PS Ratio is 17.46, which is 35% above median its own 10-year median of 12.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current PS Ratio of 17.46. The current PS Ratio is 17.46, which is 35% above median its 10-year median of 12.98 and 1048.7% above the Healthcare Providers & Services industry median of 1.52. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current PS Ratio is 17.46 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
